Abstract
The three-dimensional structure of the GABAA receptor that included the ligand/agonist binding site was constructed and validated by using molecular modeling technology. Moreover, the putative binding-mode of GABA and diazepam with GABAA receptor were investigated by means of docking studies. Based on an rmsd-tolerance of 1.0 Å, the docking of GABA to α1/β2 interface resulted in three multi-member conformational clusters and model 2 was supported by homologous sequence alignment data and experimental evidence. On the other hand, the docking of diazepam to α1/γ2 interface revealed five multi-member conformational clusters in the binding site and model 1 seemed to represent the correct orientation of diazepam in the binding site.
Similar content being viewed by others
Abbreviations
- GABA:
-
γ-Aminobutyric acid
- GABAA :
-
Receptors: type A receptors of GABA
- BZ:
-
Benzodiazepines
- AchBP:
-
Acetylcholine-binding protein
- LGIC:
-
Ligand-gated ion channels
- DOPE:
-
Discrete optimized potential energy
- ADT:
-
AutoDockTools
- HEK:
-
Human embryonic kidney
- nACh receptor:
-
Nicotinic acetylcholine receptor
Refernences
Barnard EA (1992) Trends Biochem Sci 17:368–374
Schofield PR, Darlison MG, Fujita N, Burt DR, Stephenson FA, Rodriguez H, Rhee LM, Ramachandran J, Reale V, Glencorse TA (1987) Nature 328:221–227
Shi H, Tsang SY, Tse MK, Xu Z, Xue H (2003) Protein Sci, 12:2642–2646
Buhr A, Bianchi MT, Baur R, Courtet P, Pignay V, Boulenger JP, Gallati S, Hinkle DJ, Macdonald RL, Sigel E (2002) Hum Genet 111:154–160
Wafford KA (2005) Curr Opin Pharmacol 5:47–52
Barnard EA, Skolnick P, Olsen RW, Mohler H, Sieghart W, Biggio G, Braestrup C, Bateson AN, Langer SZ (1998) Pharmacol Rev 50:291–313
Sieghart W (1995) Pharmacol Rev 47:181–234
Korpi ER, Grunder G, Luddens H (2002) Prog Neurobiol 67:113–159
Minier F, Sigel E (2004) Proc Natl Acad Sci USA 101:7769–7774
Brejc K, van Dijk WJ, Klaassen RV, Schuurmans M, van Der Oost J, Smit AB, Sixma TK (2001) Nature 411:269–276
Smit AB, Syed NI, Schaap D, van Minnen J, Klumperman J, Kits KS, Lodder H, van der Schors RC, van Elk R, Sorgedrager B, Brejc K, Sixma TK, Geraerts WP A (2001) Nature 411:261–268
Campagna-Slater V, Weaver DF (2006) J Mol Graph Model (Epub ahead of print)
Ernst M, Bruckner S, Boresch S, Sieghart WC (2005) Mol Pharmacol 68:1291–1300
Harrison NJ, Lummis SC R (2006) J Mol Model 12:317–324
Le Novere N, Grutter T, Changeux JP (2002) Proc Natl Acad Sci USA 99:3210–3215
Trudell J (2002) Biochim Biophys Acta 1565:91–96
Reeves DC, Sayed MF, Chau PL, Price KL, Lummis SC (2003) Biophys J 84:2338–2344
Thompson JD, Higgins DG, Gibson TJ (1994) Nucleic Acids Res 22:4673–4680
Sali A, Blundell TL (1993) J Mol Biol 234:779–815
Eramian D, Shen MY, Devos D, Melo F, Sali A, Marti-Renom MA (2006) Protein Sci 15:1653–1566
Fiser A, Do RK, Sali A (2000) Protein Sci 9:1753–1773
Guex N, Peitsch MC (1997) Electrophoresis 18:2714–2723
Laskowski RA, MacArthur MW, Moss DS, Thornton JM (1993) J Appl Cryst 26:283–291
Morris AL, MacArthur MW, Hutchinson EG, Thornton JM (1992) Proteins 12:345–364
Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJ (1998) J Comput Chem 19:1639–1662
Allinger NL (1977) J Am Chem Soc 99:8127–8134
Gasteiger J, Marsili M (1980) Tetrahedron 36:3219–3288,
Sanner MF (1999) J Mol Graph Model 17:57–61
Cornell WD, Cieplak P, Bayly CI, Gould IR, Merz KM Jr, Ferguson DM, Spellmeyer DC, Fox T, Caldwell JW, Kollman PA (1995) J Am Chem Soc 117:5179–5197
Wallace AC, Laskowski RA, Thornton JM (1995) Protein Eng 8:127–134
Klausberger T, Sarto I, Ehya N, Fuchs K, Furtmuller R, Mayer B, Huck S, Sieghart W (2001) J Neurosci 21:9124–9133
Taylor PM, Connolly CN, Kittler JT, Gorrie GH, Hosie A, Smart TG, Moss SJ (2000) J Neurosci 20:1297–1306
Berezhnoy D, Nyfeler Y, Gonthier A, Schwob H, Goeldner M, Sigel E (2004) J BiolChem 279:3160–3168
Boileau AJ, Evers AR, Davis AF, Czajkowski C (1999) J Neurosci 19:4847–4854
Cromer BA, Morton CJ, Parker MW (2002) Trends Biochem Sci 27:280–287
Hartvig L, Lukensmejer B, Liljefors T, Dekermendjian K (2000) J Neurochem 75:1746–1753
Smith GB, Olsen RW (1994) J Biol Chem 269:20380–20387
Sigel E, Buhr A (1997) Trends Pharmacol Sci 18:425–429
Sigel E, Baur R, Kellenberger S, Malherbe P, (1992) EMBO J 11:2017–2023
Drafts BC, Fisher JL (2004) J Pharmacol Exp Ther 309:1108–1115
Sedelnikova A, Smith CD, Zakharkin SO, Davis D, Weiss DS, Chang Y (2005) J Biol Chem 280:1535–1542
Boileau AJ, Newell JG, Czajkowski C (2002) J Biol Chem 277:2931-2937
Beene DL, Brandt GS, Zhong W, Zacharias NM, Lester HA, Dougherty DA (2002) Biochemistry 41:10262–10269
Zhong W, Gallivan JP, Zhang Y, Li L, Lester HA, Dougherty DA (1998) Proc Natl Acad Sci USA 95:12088–12093
Amin J, Weiss DS (1993) Nature 366:565–569
Wagner DA, Czajkowski C (2001) J Neurosci 21:67–74
Grutter T, Changeux JP (2001) Trends Biochem Sci 26:459–463
Pritchett DB, Seeburg PH (1990) J Neurochem 54:1802–1804
Wieland HA, Luddens H, Seeburg PH (1992) J Biol Chem 267:1426–1429
Buhr A, Schaerer MT, Baur R, Sigel E (1997) Mol Pharmacol 52:676–682
Wang D, Chiara DC, Xie Y, Cohen JB (2000) J Biol Chem 275:28666–28674
Buhr A, Baur R, Sigel E (1997) J Biol Chem 272:11799–11804
Kucken AM, Wagner DA, Ward PR, Teissere JA, Boileau AJ, Czajkowski C (2000) Mol Pharmacol 57:932–939
Buhr A, Sigel E (1997) Proc Natl Acad Sci USA 16:8824–8829
Mihic SJ, Whiting PJ, Klein RL, Wafford KA, Harris RA (1994) J Biol Chem 269:32768–32773
Acknowledgments
The present work was financially supported by the National Natural Science Foundation of China (No. 20672113) and the National 973 Program of China (Contract No. 2003CB114400).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ci, S., Ren, T. & Su, Z. Investigating the Putative Binding-mode of GABA and Diazepam within GABAA Receptor Using Molecular Modeling. Protein J 27, 71–78 (2008). https://doi.org/10.1007/s10930-007-9109-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10930-007-9109-9